President Trump’s agreement with major pharmaceutical companies to reduce drug prices deserves more than a quick partisan reaction. It sits at the crossroads of health-care economics, executive power, and moral responsibility, and it raises a question Americans should keep asking long after the headlines fade: will this actually help patients, or is it merely another…
RFK Jr. at HHS: Trump’s Wild Card Pick and the Conservative Dilemma
Robert F. Kennedy Jr.’s nomination to lead the Department of Health and Human Services (HHS) was always going to be a political lightning rod, but his Senate confirmation hearing turned into an all-out battle over science, ideology, and the soul of the conservative movement. The spectacle exposed deep political and philosophical divisions: Democrats, who have…
The Independent Christian Conservative 